Translational Research in Stroke

Grant number: 251525

Abstract

Many new therapies are being developed to treat stroke and prevent its recurrence. While a number of these have been successfully introduced, there is a puzzling gap between evidence of efficacy in animal models and humans. One of the main reasons may be lack of an integrated approach between the basic sciences and clinical researchers. By assembling a team with skills in both areas and a structure to maximise communication between groups this team plan to incrementally introduce new therapies into clinical practice.

Related publications (2)

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins to prevent stroke (VITATOPS) trial: A randomised, double-blind, parallel, placebo-controlled trial

GJ Hankey, JW Eikelboom, RI Baker, A Gelavis, SC Hickling, K Jamrozik, FM van Bockxmeer, S Vasikaran, C Chen, KR Lees, Q Yi, A Algra, MC Wong, R Cheung, L Wong, I Divjak, J Ferro, G de Freitas, J Gommans, S Groppa

2010-01-01

Background Epidemiological studies suggest that raised plasma concentrations of total homocysteine might be a risk factor for majo..

F‐18 labelled N,N‐bis‐haloethylamino‐phenylsulfoxides — a new class of compounds for the imaging of hypoxic tissue

Cheryl L Falzon, Uwe Ackermann, Neil Spratt, Henri J Tochon‐Danguy, Jonathon White, David Howells, Andrew M Scott

2006-10-30

<jats:title>Abstract</jats:title><jats:p>Two <jats:italic>N</jats:italic>,<jats:italic>N</jats:italic>‐<jats:italic>bis</jats:ital..

University of Melbourne Researchers

Geoffrey Donnan

Stephen Davis